Liposomal targeting of Bcl-2 antisense oligonucleotides with enhanced stability into human myeloma cell lines

Leukemia and Lymphoma

Volumn 24, Issue 1-2, 1996, Pages 165-174

  Ollikainen, Hanna ^a,d   Lappalainen, Katriina ^a   Jääskeläinen, Ilpo ^b   Syrjänen, Stina ^b,c   Pulkki, Kari ^a,d  

^a UNIVERSITY OF TURKU   (Finland)

^b UNIVERSITY OF TURKU   (Finland)

^c UNIVERSITY OF EASTERN FINLAND   (Finland)

^d TURKU UNIVERSITY HOSPITAL   (Finland)

Author keywords

Antisense oligonucleotides; Bcl 2; Cationic liposomes; Multiple myeloma

Indexed keywords

ANTISENSE OLIGONUCLEOTIDE; DIOLEOYLPHOSPHATIDYLETHANOLAMINE; LIPOSOME; MESSENGER RNA; PHOSPHORUS; PROTEIN BCL 2;

ARTICLE; CANCER CELL CULTURE; CELL PROLIFERATION; CONTROLLED STUDY; DRUG DELIVERY SYSTEM; DRUG STABILITY; DRUG TARGETING; GEL ELECTROPHORESIS; HUMAN; HUMAN CELL; IMAGE ANALYSIS; MYELOMA CELL; ONCOGENE; PRIORITY JOURNAL;

CATIONS; CELL DIFFERENTIATION; CELL DIVISION; DRUG CARRIERS; DRUG STABILITY; GENE EXPRESSION REGULATION, NEOPLASTIC; GENE TARGETING; GENES, BCL-2; HUMANS; LIPOSOMES; MULTIPLE MYELOMA; OLIGONUCLEOTIDES, ANTISENSE; PHOSPHATIDYLETHANOLAMINES; QUATERNARY AMMONIUM COMPOUNDS; TUMOR CELLS, CULTURED;

EID: 0030480567     PISSN: 10428194     EISSN: None     Source Type: Journal    
DOI: 10.3109/10428199609045725     Document Type: Article

References (43)

1. Niesvizky, R., Siegel, D. and Michaeli, J. (1993), Biology and treatment of multiple myeloma, Blood Rev., 7, 24-33.
2. Calabretta, B. (1991). Inhibition of protooncogene expression by antisense oligodeoxynucleotides: biological and therapeutical implications, Cancer Res., 51, 4505-4510.
3. Carter, G. and Lemoine, N. R. (1993). Antisense technology for cancer therapy: does it make sense?, Br. J. Cancer., 67, 869-876.
4. Milligan, J. F., Matteucci, M. D and Martin, J. C. (1993) Current concepts in antisense drus design, J. Med. Chem., 36, 1923-1937.
5. Vaux, D. L., Cory, S. and Adams, J. M. (1988). Bcl-2 gene promotes haemopoietic cell survival and cooperates with c-myc to immortalize pre-B cells, Nature, 335, 440-442.
6. Hockenbery, D., Nunez, G., Milliman, C., Schreiber, R. D. and Korsmayer, S. J. (1990). Bcl-2 is an inner mitochondrial membrane protein that blocks programmed cell death, Nature, 348, 334-336.
7. Nunez, G., London, L., Hockenbery, D., Alexander, M., McKearn, J. P. and Korsmayer, S. J. (1990). Deregulated bcl-2 gene expression selectively prolongs survival of growth factor-deprived hemopoietic cell lines. J. Immunol., 144, 3602-3610
8. Reed, J. C., Stein, C., Subasinghe, C., Haldar, S., Croce, C. M., Yum, S. and Cohen, J. (1990). Antisense-mediated inhibition of bcl-2 protooncogene expression and leukemic cell growth and survival: comparisons of phosphodiester and phosphorothioate oligodeoxynucleotides, Cancer Res., 50, 6565-6570.
9. Campos, L., Sabido, O., Rouault, J.-P and Guyotat, D. (1994) Effects of BCL-2 antisense olgodeoxynucleotides on in vitro proliferation and survival of normal marrow progenitors and leukemic cells, Blood, 84, 595-600.
10. Kitada, S., Takayama, S., De Riel, K., Tanaka, S., Reed, J. C. (1994). Reversal of chemoresistance of lymphoma cells by antisense-mediated reduction of bcl-2 gene expression, Antisense Res. Dev , 4, 11-19.
11. Levy, Y., Tsapis, A. and Brouet, J.-C. (1991). Interleukin-6 antisense oligonucleotides inhibit the growth of human myeloma cell lines, J Clin. Invest., 88, 696-699.
12. Schwab, G., Siegall, C. B., Aarden, L. A., Neckers, L. M. and Nordan, R. P. (1991). Characterization of an interleukin-6-mediated autocrine growth loop in the human multiple myeloma cell line, U266, Blood, 77, 587-593.
13. Sburlati, A. R., Manrow, R. E. and Berger, S. L. (1991). Prothymosin α antisense oligomers inhibit myeloma cell division, Proc Natl Acad Sci. USA., 88, 253-257.
14. Jaroszewski, J. W. and Cohen, J. S. (1991). Cellular uptake of antisense oligodeoxynucleotides, Adv. Drug Deliv. Rev., 6, 235-250.
15. Wagner, E., Zenke, M., Gotten, M., Beug, H. and Birnstiel, M. L. (1990). Transferrin-polycation conjugates as carriers for DNA uptake into cells, Proc. Natl. Acad. Sci. USA., 87, 3410-3414.
16. Clarenc, J. P., Degols, G., Leonetti, J. P., Milhaud, P. and Lebleu, B. (1993). Delivery of antisense oligonucleotides by poly(L-lysine) conjugation and liposome encapsulation, Anticancer Drug Des., 8, 81-94.
17. Krieg, A. M., Tonkinson, J., Matson, S., Zhao, Q., Saxon, M., Zhang, L.-M., Bhanja, U., Yakubov, L. and Stein, C. A. (1993). Modification of antisense phosphodiester oligodeoxynucleotides by a 5′ cholesteryl moiety increases cellular association and improves efficacy, Proc. Natl. Acad. Sci. USA., 90, 1048-1052.
18. Chow, T. Y.-K., Juby, C. and Brousseau, R. (1994). Specific targeting of antisense oligonucleotides to neutrophils, Antisense Res. Dev., 4, 81-86.
19. Akhtar, S., Kole, R. and Juliano, R. L. (1991). Stability of antisense DNA oligodeoxynucleotide analogs in cellular extracts and sera, Life Sciences, 49, 1793-1801.
20. Smith, C. C., Aurelian, L , Reddy, M. P., Miller, P. S. and Ts'o, P O. P. (1986). Antiviral effect of an oligo(nucleoside methylphosphonate) complementary to the splice junction of herpes simplex virus type 1 immediate early pre-mRNAs 4 and 5, Proc Natl Acad. Sci. USA., 83, 2787-2791.
21. Gao, W.-Y., Storm, C., Egan, W. and Cheng, Y.-C. (1993). Cellular pharmacology of phophorotioate homooligodeoxynucleotides in human cells, Mol. Pharmacol., 43, 45-50.
22. Bennett, C. F., Chiang, M.-Y., Chan, H., Shoemaker, J. E. E. and Mirabelli, C. K. (1992). Cationic lipids enhance cellular uptake and activity of phosphorotioate antisense oligonucleotides, Mol. Pharmacol., 41, 1023-1033.
23. Capaccioli, S , Di Pasquale, G., Mini, E., Mazzei, T. and Quattrone, A. (1993). Cationic lipids improve antisense oligonucleotide uptake and prevent degradation in cultured cells and in human serum, Biochem. Biophys. Res. Commun , 197, 818-825.
24. Lappalainen, K., Urtti, A., Soderling, E., Jääbkeläinen, I., Syrjänen, K. and Syrjänen, S. (1994). Cationic liposomes improve stability and intracellular delivery of antisense oligonucleotides into CaSki cells, Biochim. Biophys Acta, 1196, 201-208.
25. Thierry, A. R., Rahman, A. and Dritschilo, A. (1992). Liposomal delivery as a new approach to transport antisense oligonucieotides. In Gene Regulation, Biology of Antisense RNA and DNA, edited by R. P. Erickson and J. G Izantt, pp. 147-161. New York: Raven Press.
26. Temsamani, J., Kebert, M., Tang, J., Padmapriya, A. and Agarawal, S. (1994). Cellular uptake of oligodeoxynucleotide phosphorotioates and their analogs, Antisense Res. Dev , 4, 35-42.
27. Nilsson, K., Bennich, H., Johansson, S. G. O. and Ponten, J. (1970) Established immunoglobulin producing myeloma (IgE) and lymphoblastoid (IgG) cell lines from an IgE myeloma patient, Clin. Exp. Immunol., 7, 477-489.
28. Matsuoka, Y., Moore, G. E., Yagi, Y. and Pressman, D. (1967). Production of free light chains of immunoglobulin by a hematopoietic cell line derived from a patient with multiple myeloma, Proc. Soc. Exp. Biol. Med., 125, 1246-1250.
29. Goldblum, R., Goldman, A. S , Rudloff, B. and Harris, N. S. (1973). An enhancing factor for in vitro growth of human plasma cells. In Proceedings of the Seventh leucocytes culture conference, edited by F. Dauillard, pp. 15-28 New York: Academic Press.
30. Borset, M., Helseth, E., Naume, B. and Waage, A. (1993). Lack of IL-1 secretion from human myeloma cells highly purified by immunomasnetic separation, Br. J. Haemat., 85, 446-451
31. Rose, J. K., Buonocore, L. and Whitt, M. A. (1991). A new cationic liposome reagent mediating nearly quantitative transfection of animal cells, Biotechniques, 10, 520-525
32. Jääskeläinen, I., Mönkkönen, J., Urtti, A. (1994). Oligonucleotide-cationic liposome interactions. A physiochemical study, Biochim. Biophys Acta, 1195, 115-123
33. 125I-epidermal growth factor in BALE 3T3 cells, J. Biol. Chem., 255, 1239-1241.
34. Gao, W.-Y., Jarozewski, J. W., Cohen, J. S. and Cheng, Y. C. (1990). Mechanisms of inhibition of herpes simplex virus type 2 growth by 28-mer phophorotioate oligodeoxycytidine, J. Biol. Chem., 265, 20172-20178.
35. Chomczynski, P. and Sacchi, N. (1987). Single-step method of RNA isolation by acid guanidium thiocyanate-phenol-chloroform axtraction, Anal. Biochem , 162, 156-159.
36. Lappalainen, K., Urtti, A., Jääskeläinen, I., Syrjänen, K. and Syrjänen, S. (1994). Cationic liposomes mediated delivery of antisense oligonucleotides targeted to HPV 16 mRNA in CaSki cells, Antiviral Res., 23, 119-130.
37. Lappalainen, K., Miettinen, R., Kellokoski, J., Jaäskeläinen, I. and Syrjänen, S. Uptake and intracellular distribution of liposomal oligonucleotides in CaSki cells at ultrastructural level. Submitted for publication.
38. Woolf, T. M., Jennings, C. G. B., Rebagliati, M. and Melton, D. A. (1990). The stability, toxicity and effectiveness of unmodified and phosphorotioate antisense oligodeoxynucleotides in Xenopus oocytes and embryos, Nucleic Acids Res., 18, 1763-1769.
39. Cazenave, C., Stein, C. A., Loreau, N., Thuong, T., Neckers, L. M., Subasinghe, C., Helene, C., Cohen, S. and Toulme, J.-J. (1989). Comparative inhibition of rabbit globin mRNA translation by modified antisense oligodeoxynucleotides, Nucleic Acids Res., 17, 4255-4273.
40. Yaswen, P., Stampfer, M. R., Ghosh, K. and Cohen, J S. (1993). Effects of sequence of thioated oligonucleotides on cultured human mammary epithelial cells, Antisense Res. Dev., 3, 67-77.
41. Reed, J. C., Cuddy, M., Haldar, S., Croce, C., Nowell, P., Makover, D. and Bradley, K. (1990). BCL2-mediated tumorigenicity of a human T-lymphoid cell line: Synergy with MYC and inhibition by BCL2 antisense, Proc. Natl. Acad. Sci. USA., 87, 3660-3664.
42. Krieg, A. M , Yi, A.-K , Matson, S., Waldschmidt, T. J., Bishop, G. A , Tesdale, R., Koretzky, G. A. and Klinman, D. M. (1995). CpG motifs in bacterial DNA trigger direct B-cell activation, Nature, 374, 546-549.
43. Lappalainen, K., Jääskeläinen, I., Syrjanen, K., Urtti, A. and Syrjänen, S. (1994) Comparison of cell proliferation and toxicity assays using two cationic liposomes, Pharm. Res., 11, 1127-1131